Actively Recruiting
Evaluation of Paro, a Therapeutic Assistance Robot in Analgesic Management During the Placement of a Peripheral Intravenous Line in Infants and Children.
Led by Fondation Lenval · Updated on 2026-05-13
120
Participants Needed
4
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Peripheral intravenous catheterization is one of the most frequently performed procedures in pediatric emergency departments and hospital units. It is often associated with significant anxiety in both children and their parents, which may exacerbate the pain experienced during the procedure, as fear and pain are closely interrelated. Effective management of pain and anxiety is therefore essential to optimize the child's well-being in the short, medium, and long term. The quality of pediatric analgesia relies on a multimodal approach combining pharmacological and non-pharmacological interventions. In recent years, several non-pharmacological strategies have been developed to reduce pain and anxiety. Among these, innovative technologies such as therapeutic assistance robots incorporating artificial intelligence have emerged; however, their clinical benefits remain to be established. The present study aims to evaluate the effectiveness of PARO, a therapeutic assistance robot designed in the form of a baby seal, in the management of pain during peripheral intravenous catheterization in children. The investigators will compare the effects of PARO in combination with standard care versus standard care alone during needle-related procedures. The primary objective is to determine whether the use of this device improves pain management in children undergoing skin puncture. This study is designed as a multicenter, randomized, open-label, superiority trial conducted across five pediatric centers. A total of 120 infants and children aged 12 months to 7 years undergoing peripheral intravenous catheterization will be enrolled. Pain will be assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) observational scale, which is validated for this age group. Secondary objectives include the assessment and comparison of procedural distress between groups using the PRIC (Procedural Restraint Intensity in Children) score, evaluation of heart rate variability, number of catheterization attempts, parental anxiety measured by the STAI (State-Trait Anxiety Inventory), and satisfaction levels among both parents and healthcare staff.
CONDITIONS
Official Title
Evaluation of Paro, a Therapeutic Assistance Robot in Analgesic Management During the Placement of a Peripheral Intravenous Line in Infants and Children.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 12 months and 7 years
- Requires peripheral intravenous catheterization
- Written informed consent from at least one parent or legal guardian
- Affiliated with the national health insurance system (social security)
You will not qualify if you...
- Requires contact isolation due to colonization or infection with multidrug-resistant organisms
- Has visual or hearing impairment
- Has a known psychiatric disorder
- Unable to understand French
- Life-threatening emergency needing immediate intervention
- Requires strong analgesic medication such as morphine, ketamine, or intranasal analgesics
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Chu Morvan
Brest, France
Not Yet Recruiting
2
Centre hospitaliers de Grasse
Grasse, France
Not Yet Recruiting
3
Fondation Lenval Hôpitaux pédiatrique Nice CHU Lenval
Nice, France, 06000
Actively Recruiting
4
CHU de NICE
Nice, France
Actively Recruiting
Research Team
A
ALINE JOULIE, PHD
CONTACT
J
Jennifer BATTISTA, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here